Try our beta test site
1 study found for:    18224661 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
Condition: Malignant Mesothelioma
Interventions: Drug: epirubicin hydrochloride;   Drug: gemcitabine hydrochloride

Study has passed its completion date and status has not been verified in more than two years.